HomeMarketsSharesMapfre, S.A.

Trade Mapfre, S.A. - MAP CFD

4.26+1.43%
The chart shows the MAP stock price data over the last 1 day, with a current price of 4.26, a high of 4.25, and a low of 4.21.
Low: 4.21High: 4.25
Sellers:
16.6667%
Buyers:
83.3333%
Past performance is not a reliable indicator of future results. Share prices are indicative and may differ from live market prices.
Trading Conditions
Type
This financial market is available for CFD trading.
Learn more about:CFDs
CFD
Spread0.02
Long position overnight funding adjustment
Long position overnight funding adjustment

Margin. Your investment
€1,000.00
Overnight funding adjustment
Charges from full value of position
-0.018013 %
(-€3.60)

Trade size with leverage ~ €20,000.00

Money from leverage ~ $€19,000.00


-0.01801%
Short position overnight funding adjustment
Short position overnight funding adjustment

Margin. Your investment
€1,000.00
Overnight funding adjustment
Charges from full value of position
-0.004209 %
(-€0.84)

Trade size with leverage ~ €20,000.00

Money from leverage ~ $€19,000.00


-0.00421%
Overnight funding adjustment time21:00 (UTC)
CurrencyEUR
Min traded quantity10
Margin5.00%
Stock exchangeSpain
Commission on trade10%
Guaranteed stop premium
A guaranteed stop-loss (GSL) fee is only charged if the GSL is triggered. Please consult the Charges and Fees section of our website for more details.
1%

1Our charge for executing your trade is the spread, the difference between the buy and sell price. Please consult the Charges and Fees section of our website for further information

Key Stats
Prev. Close4.2
Open4.25
1-Year Change2.66%
Day's Range4.21 - 4.25

Trade Mapfre, S.A. - MAP

About Mapfre SA

Mapfre SA is a Spain-based company engaged in the insurance sector. The Company's activities are divided into four business units: Insurance, Assistance, Reinsurance and Global Risks. The Insurance line offers insurance policies, including life, accident, health, property and casualty and automotive insurance, among others. The Assistance line focuses on developing assistance services for insurance products, including road and travel assistance. The Reinsurance line is responsible for reinsurance activities. The Global Risks line offers integrated insurance services, such as risk prevention and protection, audit and control, for business customers. In addition, the Company is active in the management of pension funds, retirement plans and investment funds, as well as the provision of healthcare services in Spain. The Company operates in Europe, Africa, Asia and the Americas. It is a parent of the Mapfre Group.

Financial summary

BRIEF: For the fiscal year ended 31 December 2021, Mapfre SA revenues increased 7% to EUR20.61B. Net income applicable to common stockholders increased 45% to EUR765.2M. Revenues reflect Non-Life segment increase of 25% to EUR5.13B, Reinsurance segment increase of 10% to EUR6.27B. Net income benefited from Negative foreign exchange differences decrease of 22% to EUR1.57B (expense).

Equity composition

10/2006, 5-for-1 stock split. 11/2008, Rights Issue, 1 new share for every 39 shares held @ EUR 2.21 (Factor: 1.00282). 03/2009, Rights Issue, 1 new share for every 22 shares held @ EUR 1.41 (Factor:1.0047). 11/2009, Rights Issue, 1 new shares for every 45 shares held @ EUR 2.583 (Factor: 1.00364). 06/2011, Rights Issue, 1-for-39 (1.00103)

Latest shares articles

A GameStop store in Portland, Oregon
GameStop stock forecast: debt exchange, Q2 profit
GameStop is a US video-game retailer. In Q2 fiscal 2026, net sales fell to $790.2m, while operating income rose to $160.2m. Explore third-party GME price targets and technical analysis. Past performance is not a reliable indicator of future results.
14:06, 7 October 2026
Freenet stock forecast
Freenet stock forecast: revenue rises, EBITDA falls
Freenet reported first-half 2026 revenue of €1,512.9 million, up 24.7% year on year, while adjusted EBITDA fell 5.9% to €242.2 million and 2026 guidance was maintained. Explore third-party FNTN price targets and technicals. Past performance is not a reliable indicator of future results.
12:41, 7 October 2026
Hims & Hers Health stock forecast
Hims & Hers Health stock forecast: FDA GLP-1 warning
Hims & Hers Health is a US telehealth company. In August 2026, the FDA issued a warning concerning unapproved compounded GLP-1 weight-loss drugs. Explore third-party HIMS price targets and technical analysis. Past performance is not a reliable indicator of future results.
12:18, 7 October 2026
Arm Holdings stock forecast
Arm Holdings stock forecast: Haas flags AI demand
Arm Holdings is a UK-based semiconductor company. Chief executive Rene Haas said AI and data-centre demand showed no signs of slowing. Explore third-party ARM price targets and technical analysis. Past performance is not a reliable indicator of future results.
09:43, 6 October 2026

User feedback and ratings

Showing our 4 & 5 star reviews. The specific details of the user have been intentionally anonymised to safeguard their privacy pursuant to GDPR requirements.

Ready to join a leading broker?

1. Create your account2. Make your first deposit3. Start when you’re ready